
Jeffrey E. Russel
Examiner (ID: 13185, Phone: (571)272-0969 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1815, 1103, 1621, 1811, 1653, 1675, 2899, 1654, 1809 |
| Total Applications | 3437 |
| Issued Applications | 2371 |
| Pending Applications | 237 |
| Abandoned Applications | 837 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5597071
[patent_doc_number] => 20060160989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Polypeptide useful as antiallergic/antiasthmatic activity, methods for the preparation thereof, pharmaceutical compositions containing such polypeptide and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/740752
[patent_app_country] => US
[patent_app_date] => 2003-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12055
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160989.pdf
[firstpage_image] =>[orig_patent_app_number] => 10740752
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/740752 | Polypeptide useful as antiallergic/antiasthmatic activity, methods for the preparation thereof, pharmaceutical compositions containing such polypeptide and use thereof | Dec 21, 2003 | Abandoned |
Array
(
[id] => 698470
[patent_doc_number] => 07067273
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-27
[patent_title] => 'Peptide substrates of a proteolytic ADAM33 polypeptide and assays using the same'
[patent_app_type] => utility
[patent_app_number] => 10/741205
[patent_app_country] => US
[patent_app_date] => 2003-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10387
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/067/07067273.pdf
[firstpage_image] =>[orig_patent_app_number] => 10741205
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/741205 | Peptide substrates of a proteolytic ADAM33 polypeptide and assays using the same | Dec 18, 2003 | Issued |
Array
(
[id] => 7446703
[patent_doc_number] => 20040186045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => 'Compositions and methods for enhancing drug delivery across and into epithelial tissues'
[patent_app_type] => new
[patent_app_number] => 10/740365
[patent_app_country] => US
[patent_app_date] => 2003-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 35996
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20040186045.pdf
[firstpage_image] =>[orig_patent_app_number] => 10740365
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/740365 | Compositions and methods for enhancing drug delivery across and into epithelial tissues | Dec 16, 2003 | Abandoned |
Array
(
[id] => 5649673
[patent_doc_number] => 20060135408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Glycogen synthase kinase-3 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/538171
[patent_app_country] => US
[patent_app_date] => 2003-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 23614
[patent_no_of_claims] => 95
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20060135408.pdf
[firstpage_image] =>[orig_patent_app_number] => 10538171
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/538171 | Glycogen synthase kinase-3 inhibitors | Dec 10, 2003 | Issued |
Array
(
[id] => 7305906
[patent_doc_number] => 20040116351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-17
[patent_title] => 'Method for enhancing the natural reward system for exercise'
[patent_app_type] => new
[patent_app_number] => 10/730627
[patent_app_country] => US
[patent_app_date] => 2003-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5634
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20040116351.pdf
[firstpage_image] =>[orig_patent_app_number] => 10730627
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/730627 | Method for enhancing the natural reward system for exercise | Dec 7, 2003 | Abandoned |
Array
(
[id] => 7674721
[patent_doc_number] => 20040127397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-01
[patent_title] => 'Active agent delivery systems and methods for protecting and administering active agents'
[patent_app_type] => new
[patent_app_number] => 10/727565
[patent_app_country] => US
[patent_app_date] => 2003-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4984
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20040127397.pdf
[firstpage_image] =>[orig_patent_app_number] => 10727565
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/727565 | Active agent delivery systems and methods for protecting and administering active agents | Dec 4, 2003 | Abandoned |
Array
(
[id] => 5643231
[patent_doc_number] => 20060281686
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-14
[patent_title] => 'Aza-peptides'
[patent_app_type] => utility
[patent_app_number] => 10/537246
[patent_app_country] => US
[patent_app_date] => 2003-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12690
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20060281686.pdf
[firstpage_image] =>[orig_patent_app_number] => 10537246
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/537246 | Aza-peptides | Nov 30, 2003 | Abandoned |
Array
(
[id] => 7224394
[patent_doc_number] => 20040072738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Analogues of thiocoraline and be-22179'
[patent_app_type] => new
[patent_app_number] => 10/433178
[patent_app_country] => US
[patent_app_date] => 2003-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11018
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20040072738.pdf
[firstpage_image] =>[orig_patent_app_number] => 10433178
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/433178 | Analogues of thiocoraline and be-22179 | Nov 23, 2003 | Abandoned |
Array
(
[id] => 571006
[patent_doc_number] => 07462689
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-09
[patent_title] => 'Hydrazine-based and carbonyl-based bifunctional crosslinking reagents'
[patent_app_type] => utility
[patent_app_number] => 10/720843
[patent_app_country] => US
[patent_app_date] => 2003-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15838
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/462/07462689.pdf
[firstpage_image] =>[orig_patent_app_number] => 10720843
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/720843 | Hydrazine-based and carbonyl-based bifunctional crosslinking reagents | Nov 23, 2003 | Issued |
Array
(
[id] => 7024993
[patent_doc_number] => 20050019387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Liposomal formulation of irinotecan'
[patent_app_type] => utility
[patent_app_number] => 10/717378
[patent_app_country] => US
[patent_app_date] => 2003-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2588
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20050019387.pdf
[firstpage_image] =>[orig_patent_app_number] => 10717378
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/717378 | Liposomal formulation of irinotecan | Nov 18, 2003 | Issued |
Array
(
[id] => 162552
[patent_doc_number] => 07671026
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-02
[patent_title] => 'Cytomodulating peptides for treating interstitial cystitis'
[patent_app_type] => utility
[patent_app_number] => 10/535167
[patent_app_country] => US
[patent_app_date] => 2003-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 36
[patent_no_of_words] => 17491
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/671/07671026.pdf
[firstpage_image] =>[orig_patent_app_number] => 10535167
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/535167 | Cytomodulating peptides for treating interstitial cystitis | Nov 16, 2003 | Issued |
Array
(
[id] => 5844334
[patent_doc_number] => 20060122121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Modified alpha-MSH peptides and derivatives thereof'
[patent_app_type] => utility
[patent_app_number] => 10/714343
[patent_app_country] => US
[patent_app_date] => 2003-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7715
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20060122121.pdf
[firstpage_image] =>[orig_patent_app_number] => 10714343
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/714343 | Modified alpha-MSH peptides and derivatives thereof | Nov 13, 2003 | Abandoned |
Array
(
[id] => 695268
[patent_doc_number] => 07071167
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-07-04
[patent_title] => 'Use of a combination of components with an inhibitory synergistic effect on calcium channels to prevent or treat wrinkles and fine lines'
[patent_app_type] => utility
[patent_app_number] => 10/705857
[patent_app_country] => US
[patent_app_date] => 2003-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6551
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/071/07071167.pdf
[firstpage_image] =>[orig_patent_app_number] => 10705857
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/705857 | Use of a combination of components with an inhibitory synergistic effect on calcium channels to prevent or treat wrinkles and fine lines | Nov 12, 2003 | Issued |
Array
(
[id] => 951361
[patent_doc_number] => 06960565
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-11-01
[patent_title] => 'Compound for inhibiting the influx of polymorphonuclear leukocytes (PMNS) in a tissue, its selection, pharmaceutical compositions and use'
[patent_app_type] => utility
[patent_app_number] => 10/712985
[patent_app_country] => US
[patent_app_date] => 2003-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 3773
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/960/06960565.pdf
[firstpage_image] =>[orig_patent_app_number] => 10712985
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/712985 | Compound for inhibiting the influx of polymorphonuclear leukocytes (PMNS) in a tissue, its selection, pharmaceutical compositions and use | Nov 12, 2003 | Issued |
Array
(
[id] => 4852092
[patent_doc_number] => 20080317834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-25
[patent_title] => 'Compounds and methods for modulating cerebral amyloid angiopathy'
[patent_app_type] => utility
[patent_app_number] => 10/705028
[patent_app_country] => US
[patent_app_date] => 2003-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13924
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20080317834.pdf
[firstpage_image] =>[orig_patent_app_number] => 10705028
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/705028 | Compounds and methods for modulating cerebral amyloid angiopathy | Nov 9, 2003 | Abandoned |
Array
(
[id] => 7281249
[patent_doc_number] => 20040063626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => 'Use of cyclosporin a 7-thioamide derivatives for hair growth'
[patent_app_type] => new
[patent_app_number] => 10/432448
[patent_app_country] => US
[patent_app_date] => 2003-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5786
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20040063626.pdf
[firstpage_image] =>[orig_patent_app_number] => 10432448
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/432448 | Use of cyclosporin a 7-thioamide derivatives for hair growth | Nov 9, 2003 | Abandoned |
Array
(
[id] => 910363
[patent_doc_number] => 07329646
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-12
[patent_title] => 'Derivatives of the insulinotropic peptide exendin-4 and methods of production thereof'
[patent_app_type] => utility
[patent_app_number] => 10/704409
[patent_app_country] => US
[patent_app_date] => 2003-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 13986
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/329/07329646.pdf
[firstpage_image] =>[orig_patent_app_number] => 10704409
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/704409 | Derivatives of the insulinotropic peptide exendin-4 and methods of production thereof | Nov 6, 2003 | Issued |
Array
(
[id] => 788158
[patent_doc_number] => 06987090
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-01-17
[patent_title] => 'Use of 3-position cyclosporin derivatives for hair growth'
[patent_app_type] => utility
[patent_app_number] => 10/696268
[patent_app_country] => US
[patent_app_date] => 2003-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 9278
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/987/06987090.pdf
[firstpage_image] =>[orig_patent_app_number] => 10696268
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/696268 | Use of 3-position cyclosporin derivatives for hair growth | Oct 28, 2003 | Issued |
Array
(
[id] => 5113516
[patent_doc_number] => 20070197432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-23
[patent_title] => 'Peptides for preventing, diagnosing and treating animal and/or human leptospirosis'
[patent_app_type] => utility
[patent_app_number] => 10/533193
[patent_app_country] => US
[patent_app_date] => 2003-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17322
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20070197432.pdf
[firstpage_image] =>[orig_patent_app_number] => 10533193
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/533193 | Peptides for preventing, diagnosing and treating animal and/or human leptospirosis | Oct 23, 2003 | Issued |
Array
(
[id] => 7468626
[patent_doc_number] => 20040096453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'Methods and compositions to treat glycosaminoglycan-associated molecular interactions'
[patent_app_type] => new
[patent_app_number] => 10/690020
[patent_app_country] => US
[patent_app_date] => 2003-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 15582
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20040096453.pdf
[firstpage_image] =>[orig_patent_app_number] => 10690020
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/690020 | Methods and compositions to treat glycosaminoglycan-associated molecular interactions | Oct 19, 2003 | Abandoned |